ouabain has been researched along with everolimus in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barollo, S; Cicala, MV; Iacobone, M; Mantero, F; Mian, C; Mucignat-Caretta, C; Pezzani, R; Radu, C; Redaelli, M; Rubin, B; Salvà, M; Simioni, P | 1 |
1 other study(ies) available for ouabain and everolimus
| Article | Year |
|---|---|
The antiproliferative effects of ouabain and everolimus on adrenocortical tumor cells.
Topics: Adrenal Cortex Neoplasms; Adult; Antineoplastic Agents; Apoptosis; Caspases; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Everolimus; Female; Humans; Male; Middle Aged; Ouabain; Sirolimus | 2014 |